DAF in diabetic patients is subject to glycation/inactivation at its active site residues.
Flückiger R, Cocuzzi E, Nagaraj RH, Shoham M, Kern TS, Medof ME. DAF in diabetic patients is subject to glycation/inactivation at its active site residues. Mol Immunol. 2018 01; 93:246-252.